On Monday morning, Axios co-founder Mike Allen and Axios health care business reporter Bob Herman hosted a virtual event on the impact of the coronavirus on biomedical innovations and the challenges of making expensive treatments — like gene therapy — more accessible. They were joined by the U.S. FDA's Director of the Center for Biologics Evaluation and Research Dr. Peter Marks, Rep. Scott Peters (D-Calif.) and Real Endpoints EVP & Chief Clinical Officer Dr. Jane Barlow

Dr. Peter Marks discussed how gene therapy offers "a chance in many ways to to get things right once and for all" as it could potentially save patients a lifetime of needing to undergo disease treatments repeatedly.

  • "With gene therapy, we're going from feeding someone a fish for dinner — in the case of taking regular pills — to teaching them how to fish by taking care of them for a lifetime."

Rep. Scott Peters focused on how targeted treatments can save money in the long term for patients and the government alike.

  • On Congress' traditional resistance to new medical methods: "People, their initial reaction to technologies is that it must be more expensive. It's our job to show that it's more cost-effective over time."

Dr. Jane Barlow discussed rethinking the payment model for expensive treatments like gene therapy. She highlighted how a Netflix-type model could be used to help solve the problem of high one-time costs of gene therapy treatments compared to current medicines where the cost is spread out over time.

Thank you to The Institute for Gene Therapies for sponsoring this event.

Go deeper

The many divisions over Trump's methane rollback

Illustration: Rebecca Zisser/Axios

EPA's decision to cut regulation of methane is laying bare an oil-and-gas industry divide and setting the stage for political battles this fall and beyond.

Why it matters: Methane is an extremely powerful greenhouse gas and the industry is a key emissions source.

Kushner says Trump didn't promote false Kamala Harris birtherism theory

White House senior adviser Jared Kushner told "CBS This Morning" on Friday that he does not believe President Trump promoted a baseless claim that Sen. Kamala Harris is ineligible to be vice president.

Driving the news: During a press briefing on Thursday, Trump did not question the veracity of a Newsweek op-ed that inaccurately claimed Harris may be ineligible for the office due to her parents' naturalization status at the time of her birth. Harris is an American citizen and was born in Oakland, Calif.

Updated 1 hour ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 9 a.m. ET: 20,952,811 — Total deaths: 760,235— Total recoveries: 13,015,397Map.
  2. U.S.: Total confirmed cases as of 9 a.m. ET: 5,254,878 — Total deaths: 167,253 — Total recoveries: 1,774,648 — Total tests: 64,831,306Map.
  3. Health: The pandemic's toll on mental health — The kids who are most at risk.
  4. Business: How small businesses got stiffed — Unemployment starts moving in the right direction.
  5. Politics: Biden signals fall strategy with new ads.
  6. 🎧 Podcast: Economic data turns unreliable.